Targeted Cellular Technology®

Developed by Physician Therapeutics, Targeted Cellular Technology® is a unique, patented, five component process allows milligram quantities of neurotransmitter precursors to enter the cells and produce the required neurotransmitters. This process includes a neurotransmitter precursor, an uptake stimulator, a neuron activator, an adenosine brake inhibitor, and an attenuation releaser. Previous attempts to use neurotransmitter precursors have required much larger quantities of the precursors to elicit a therapeutic effect, making it functionally impossible for a patient to ingest gram quantities of a precursor on a daily basis. The use of the Targeted Cellular Technology process also prevents the development of tolerance. Unlike pharmaceutical agents that lose their effectiveness in a relative short period of time, Targeted Cellular Technology maintains its effectiveness and does not attenuate.

Overview of Neurotransmitter Science

Advanced Neurotransmitter Science

• TCT allows for the production of neurotransmitters from precursors
• Precursors in milligram quantities not gram quantities
• Amino acids that selectively produce neurotransmitter synthesis
• Reduced Attenuation

Amino Acids are the Precursors to Neurotransmitters

• 5 HTP Serotonin
• Choline Acetylcholine
• Arginine Nitric Oxide
• Tyrosine Catecholamines
• GABA GABA
• Histidine Histamine

 

 

 

 

TCT (Targeted Cellular Technology)

• Neurotransmitter precursor
• Uptake stimulator
• Neuron activator
• Adenosine brake inhibitor
• Attenuation inhibitor

Medical Foods Links:

• Product Summaries and Monographs
• Articles
• Clinical Research
• Medical Foods FAQ

Home | Rx Medical Foods | Commonly Asked Questions | About PDR | Contact | Forms © PDR Medical Management LLC 2010 All rights reserved